Huang Jiawen, Wang Xiangyu, Xie Liyuan, Wu Mingan, Zhao Wei, Zhang Yongbin, Wang Qi, Yao Limei, Li Weirong
Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun District, Guangzhou, 510405, China.
Laboratory Animal Center, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun District, Guangzhou, 510405, China.
J Ethnopharmacol. 2020 May 10;253:112673. doi: 10.1016/j.jep.2020.112673. Epub 2020 Feb 18.
The traditional Chinese medicine formula Danggui-Shaoyao-San (DSS) has been reported to show therapeutic effect on alleviating the symptoms of Alzheimer's disease (AD).
The present study aims to investigate the relation between DSS treatment of AD and DHA metabolism and evaluates its neuroprotective effect on cognitive in APP/PS1 mice.
DSS (1.6, 3.2, 6.4 g/kg/day) or Aricept (3 mg/kg/day) was orally administered (i.g.) to APP/PS1 mice, and saline was orally administered to Wild-type (WT) male mice as control group. Then, the Morris water maze (MWM) test, Y-maze spontaneous alternation test, open filed test and fear conditioning test were conducted for evaluation of learning and memory abilities. The DHA content was assessed by HPLC-MS/MS. Physiological indices were determined, including triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), ROS level, activity of superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA), PEG2, TXB2 and LTB4. The expressions of COX-1, COX-2, cPLA2, iPLA2, 15-LOX, and were assessed by Western blot.
APP/PS1 mice showed serious cognitive impairment in behavioral tests. However, treatment of DSS extract significantly ameliorated the cognitive deficits of APP/PS1 mice. Biochemical measurements showed the increases in TG, TC, LDL-c and the decrease in HDL-c in APP/PS1 mice compared with WT mice, and DSS extract significantly retarded these changes. Low content of DHA, low expression of iPLA2 and 15-LOX were observed both in hippocampus and cortex of APP/PS1 mice, while DSS extract significantly restored these changes. Additionally, the abnormal activity of SOD and ROS level, the decreased levels of MDA and GSH were observed in APP/PS1 mice, while DSS extract prominently lessened these changes. Moreover, DSS extract decreased the level of PEG2, TXB2 and LTB4 and also attenuated the expression of cPLA2, COX-1 and COX-2 in hippocampus as well as cortex of APP/PS1 mice.
Based on these results, we suggest that DSS play a positive effective role in increasing DHA content by up-regulating iPLA2 and 15-LOX, resulting in ameliorating oxidative stress and inflammation and finally ameliorating cognition deficits in APP/PS1 mice.
据报道,中药方剂当归芍药散(DSS)对缓解阿尔茨海默病(AD)症状具有治疗作用。
本研究旨在探讨DSS治疗AD与DHA代谢之间的关系,并评估其对APP/PS1小鼠认知功能的神经保护作用。
将DSS(1.6、3.2、6.4 g/kg/天)或多奈哌齐(3 mg/kg/天)口服给予APP/PS1小鼠,将生理盐水口服给予野生型(WT)雄性小鼠作为对照组。然后,进行莫里斯水迷宫(MWM)试验、Y迷宫自发交替试验、旷场试验和恐惧条件试验,以评估学习和记忆能力。通过HPLC-MS/MS评估DHA含量。测定生理指标,包括甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、ROS水平、超氧化物歧化酶(SOD)活性、谷胱甘肽(GSH)、丙二醛(MDA)、PEG2、TXB2和LTB4。通过蛋白质免疫印迹法评估COX-1、COX-2、cPLA2、iPLA2、15-LOX的表达。
APP/PS1小鼠在行为测试中表现出严重的认知障碍。然而,DSS提取物治疗显著改善了APP/PS1小鼠的认知缺陷。生化测量结果显示,与WT小鼠相比,APP/PS1小鼠的TG、TC、LDL-c升高,HDL-c降低,而DSS提取物显著减缓了这些变化。在APP/PS1小鼠的海马体和皮质中均观察到DHA含量低以及iPLA2和15-LOX表达低,而DSS提取物显著恢复了这些变化。此外,在APP/PS1小鼠中观察到SOD活性和ROS水平异常,MDA和GSH水平降低,而DSS提取物显著减轻了这些变化。此外,DSS提取物降低了APP/PS1小鼠海马体和皮质中PEG2、TXB2和LTB4的水平,并减弱了cPLA2、COX-1和COX-2的表达。
基于这些结果,我们认为DSS通过上调iPLA2和15-LOX在增加DHA含量方面发挥积极有效的作用,从而改善氧化应激和炎症,最终改善APP/PS1小鼠的认知缺陷。